Skip to content

Embecta Corp. EMBC Weighted-Average Discount Rate

Weighted-Average Discount Rate at other companies

ICU Medical logo
ICU MedicalICUI
6.4%+0.6pp

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Reported directly by Embecta Corp. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s weighted-average discount rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s weighted-average discount rate?
Embecta Corp. (EMBC) reported weighted-average discount rate of 6.8% in Q1 2026.
How has Embecta Corp.'s weighted-average discount rate changed year-over-year?
Embecta Corp.'s weighted-average discount rate decreased by 0.0% year-over-year, from 6.8% to 6.8%.
What is the long-term trend for Embecta Corp.'s weighted-average discount rate?
Over 3 years (2022 to 2025), Embecta Corp.'s weighted-average discount rate has grown at a 0.0% compound annual growth rate (CAGR), from 6.8% to 6.8%.
What does weighted-average discount rate mean?
This represents the average interest rate used to calculate the present value of the company's lease liabilities. It reflects the company's incremental borrowing rate or the rate implicit in the leases. This metric is essential for understanding the cost of capital embedded in the company's off-balance-sheet financing arrangements.